NGNE Financials
Neurogene Inc - Financial statements & key metrics
Stock Price
$37.87
Market Cap
$286.53M
P/E Ratio
-8.8
EPS
$-4.10
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$925,000
Gross Profit
-
Operating Income
-
Net Income
$-75.14M
EPS (Diluted)
$-4.28
Balance Sheet Highlights
Total Assets
$335.73M
Total Liabilities
$25.36M
Shareholders Equity
-
Cash & Equivalents
$136.59M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-70.60M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-42.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is NGNE revenue?
NGNE's most recent quarterly revenue was $925,000. Annual revenue can be calculated by summing the four most recent quarters.
Is NGNE profitable?
NGNE reported a loss of $75.14M in the most recent quarter.
What is NGNE market cap?
NGNE has a market capitalization of $286.53M, making it a small-cap stock.
Does NGNE have debt?
View NGNE's balance sheet for debt information.
What is NGNE cash flow?
Cash flow data is available in the full financial statements.